2023 Drug Safety Communications
- FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan) 11/28/2023
- FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions 5/11/2023
- FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use 4/13/2023